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Abstract
Background: The public and private sector in the EU spend around €800 million per year on animal health and
welfare related research. An objective process to identify critical gaps in knowledge and available control tools
should aid the prioritisation of research in order to speed up the development of new or improved diagnostics,
vaccines and pharmaceuticals and reduce the burden of animal diseases.
Method: Here, we describe the construction of a database based on expert consultation for 52 infectious diseases of animals.
Results: For each disease, an expert group produced a disease and product analysis document that formed the basis for gap
analysis and prioritisation. The prioritisationmodel was based on a closed scoring system, employing identical weights for six
evaluation criteria (disease knowledge; impact on animal health andwelfare; impact on public health; impact onwider society;
impact on trade; control tools). The diseases were classified into three groups: epizootic diseases, food-producing animal
complexes or zoonotic diseases.
Discussion: The highly ranked diseases in the prioritisation model comprised mostly zoonotic and epizootic diseases with
important gaps identified in vaccine development and pharmaceuticals, respectively. The most important outcome is the
identification of key research needs by disease. The rankings and research needs by disease are provided on a public
website (www.discontools.eu) which is currently being updated based on new expert consultations.
Conclusion: As such, it can become a reference point for funders of research including the European Commission,
member states, foundations, trusts along with private industry to prioritise research. This will deliver benefits in terms of
animal health and welfare but also public health, societal benefits and a safe and secure food supply.
Keywords: Prioritisation, Animal disease, Research needs, EU
Background
Animal diseases are estimated to reduce the production of ani-
mal products by at least 20% according to theWorldOrganisa-
tion for Animal Health (OIE) [1]. As such, the prevention and
control of animal diseases has benefits in terms of animal health
and welfare but also human health where zoonoses are con-
cerned and broad societal benefits in terms of companion ani-
mal health and the security of a safe food supply.
In terms of funding, it is estimated that the public sector
spends €400 million per year in Europe on animal health and
welfare related research [2, 3] and the private sector spends
€400 million per year on animal health research [4]. With
about €800million being spent per year, the added value of an
objective process to prioritise critical research can be appreci-
ated. By focusing a proportion of this expenditure on critical
gaps in priority diseases, it will be possible to speed up the de-
velopment and delivery of new and improved disease control
tools including diagnostics, vaccines and pharmaceuticals to
reduce the burden of disease on animals. Given that the
current value of animal based products at producer prices
in the E.U. is €154 billion per year [5], every percentage
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reduction in the impact of animal disease on production
would be of major economic importance.
During the work of the European Technology Platform
for Global Animal Health (ETPGAH)1 from 2004 to 2012,
it was recognised that disease prioritisation was one of the
most important initiatives that needed to be undertaken
to focus and prioritise research [6]. This work necessitates
the identification of gaps in knowledge as well as control
tools – diagnostics, vaccines and pharmaceuticals.
The DISCONTOOLS project was funded under the
EU 7th framework programme from 2008 to 2013 and
originated from the Action Plan of the ETPGAH. The
general objective of the project was to evaluate global
animal health priorities and the risk they could pose to
the European Union. This understanding would assist in
ensuring the most effective allocation of research funding.
The project led to the development of a disease database
containing a gap analysis and prioritisation model for 52
infectious diseases of animals. The objective of this paper
is to describe the different steps in the development of the
database (Section Construction and content), describe its
utility (Section Utility) and discuss how it could assist pol-
icy makers in targeting research funding (Section Discus-
sion). It should be noted that the focus of the database is
on research needs with respect to control tools in the form
of diagnostics, vaccines and pharmaceuticals. It does not
necessarily consider disease control strategies or other as-
pects of disease control such as disease modelling, surveil-
lance and regulatory support.
Methods
General approach
The DISCONTOOLS project was organised as shown in
Fig. 1. All European and Global organisations with an
interest in animal health research were invited to join
the Stakeholder Forum. It included organisations ran-
ging from farmers, veterinarians and the pharmaceutical
industry to chief veterinary officers, research institutes
and related projects funded by the European Commis-
sion. The Project Management Board (PMB) comprised
10 representatives from the Stakeholders selected to rep-
resent research, industry, users and public bodies. The
membership is listed in Table 1.
Five work packages or working groups were estab-
lished each reporting to the PMB. Of these two working
groups one on disease prioritisation, the other on gap
analysis were involved in developing the database (See
Fig. 1). Membership of the two working groups con-
sisted of approximately 15 people and was by invitation
along with nominations from the stakeholders and inter-
ested parties. It was important that each of the groups
was balanced with members with appropriate expertise
from research, industry, users (including farming and
veterinary profession) and regulators as well as the Euro-
pean Commission and international organisations.
The development of the database was preceded by a
review of existing processes for prioritisation and gap
analysis by the PMB in order to steer the methodology
adopted. Subsequently, the disease list was selected and
prioritisation methodology developed, followed by expert
opinion elicitation to provide content to the database.
The prioritisation methodology was subdivided in the
development of Disease & Product analysis document
(D&P), a prioritisation model and gap analysis model.
Review of existing prioritisation models
A worldwide review of existing models was carried out.
In public health, a number of studies have methodically
prioritised communicable diseases and pathogens [7–15].
In the field of animal health, most studies have focused on
Fig. 1 Organisation of the DISCONTOOLS project
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prioritisation of food-borne and zoonotic pathogens [13,
16–20]. In addition, studies have also been conducted with
the specific aims of prioritising surveillance of wildlife
pathogens [21], disease control for poverty alleviation [22],
non-regulatory animal health issues [23] and exotic dis-
eases and emerging animal health threats [24, 25].
Although methodological approaches differ, priority-
setting studies typically follow a series of steps: (i) select-
ing a group of diseases/pathogens for prioritization; (ii)
identifying a list of appropriate and measurable criteria
to assess diseases/pathogens; (iii) defining a range of levels
for each criterion; (iv) determining the relative importance
by means of a weight or score for each level and criterion;
(v) aggregating to produce an overall score for each
disease/pathogen; and (vi) ranking diseases/pathogens
by their overall score to derive a recommended list for
prioritization [26]. It was evident that risk-based priority-
setting should be systematic, flexible, reproducible and in-
formative to public policy. The criteria must be explicit,
measurable, relevant and objective wherever possible.
However, the methodology and criteria required will
depend on the goal of prioritisation, so a clear defin-
ition of the aim is essential. The priority-setting process
should be transparent and open to discussion and revi-
sion. In addition, it is considered preferable to define a
disease as specifically as possible (e.g. brucellosis of cat-
tle versus brucellosis in general) and to consider how
the model can evolve over time in order to remain of
value. On the basis of the review, and considering the
goal of DISCONTOOLS, i.e. identifying research needs
of infectious animal diseases in the EU, the main steps
which have been followed include establishing a list of
relevant infectious diseases and gathering relevant in-
formation on each disease. It was considered essential
that the scoring system allows diseases to be ranked
based on total scores and/or on scores for particular
criteria (e.g. impact on public health).
Establishment of disease list
The working groups of the DISCONTOOLS project were
created by inviting stakeholders to become involved in
WP2, WP3 and/or WP4 with the PMB taking care of
WP1 and WP5 (see Fig. 1). In parallel, the PMB invited an
expert to Chair each of WP2, WP3 and WP4. The WPs
then established a list of 52 priority diseases to be included
in the prioritisation exercise. The starting point for the list
of diseases was from the Action Plan of the ETPGAH
which referred to 47 diseases. In addition, it was consid-
ered important not to lose sight of endemic diseases or
disease syndromes (e.g. internal parasites, mastitis). There-
fore, 3 groups of diseases were defined as follows:
(1)epizootic diseases: infectious diseases which pose a
risk for introduction or spread in the EU and for
which tools for optimum detection, surveillance and
control would be beneficial;
(2)food producing animal complexes: major enzootic
diseases of livestock in Europe;
(3)zoonotic diseases: infectious diseases of animals
that are important for human health and for their
socio-economic effects.
The geographic dimension of the project was primarily
European. Naturally, where a disease was not present in
Europe, a global perspective was taken into account. The
expert groups were asked to highlight and take into ac-
count strains and species where the economic impact
was the highest not only in Europe, but worldwide.
After discussions of theworking groups ofDISCONTOOLS
a final list of 52 diseases was agreed. The list was not consid-
ered to be exhaustive, but representative of most disease sce-
narios. Infectious diseases of aquatic animals or companion
animals without a zoonotic implicationwere not considered.
Results
Prioritisation methodology
Disease and product analysis document
A D&P was developed for each disease by the working
groups of the DISCONTOOLS project in order to have
key information available prior to scoring of the different
criteria. The D&P is a reference document that provides
the detailed and relevant information for each disease
which is necessary to support the scoring for the priori-
tisation and gap analysis models. It contains 23 main
sections with sub-headings covering a wide range of aspects
Table 1 Organisations represented in the Project Management
Board of DISCONTOOLS
Organisation Description
Copa-Cogeca European union for agricultural organisations and
cooperatives
CVO’s Chief Veterinary Officers
DG Research Directorate-General for Research and Innovation
of the European Commission
EAEVE European Association of Establishments for
Veterinary Education
EMIDA ERA-net Coordination platform of research on emerging
infectious diseases of animals
EMVD European Manufacturers of Veterinary Diagnostics
EPIZONE International network of veterinary research
institutes working on epizootic animal diseases
FVE Federation of Veterinarians of Europe
HMA Heads of Medicines Agencies
IFAH-Europe International Federation for Animal Health Europe
MEDVETNET European Network of Excellence for Zoonoses
Research
OIE World organisation for animal health
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such as description and characteristics of the disease, route
of transmission, zoonotic potential, control tools available,
and socio-economic impact. The full list of sections may be
consulted at www.discontools.eu/diseases under the custom
report section. For each section, an additional column
headed “Gaps identified” was included in the D&P to gather
further information on the gaps in knowledge and products
of each disease. The document was completed by the
expert groups who were asked to reach a consensus on
the final text which was then reviewed by the PMB.
Prioritisation model
The criteria, levels within each of the criteria, scores and
weighting coefficients that were used in the prioritisation
model can be viewed in Table 2. Six criteria were
considered:
Table 2 The prioritisation model: criteria considered, levels within the criteria, scores and applied weighting coefficients (Coef)
Criteria Scores Coef Total (score*coef)
Disease knowledge 0 1 2 3 4 2.5 /100
1. Speed of spread
2. Number of species involved
3. Persistence of infectious agent in the environment
4. Risk of spread to susceptible populations
5. Potential for silent spread
6. Wildlife reservoir and potential spread
7. Vector reservoir and potential spread
8. Variability of the agent
9. Understanding of fundamental immunology
10. Host pathogen interaction
Impact on animal health and welfare 0 1 2 3 4 8.33 /100
1. Disease impact on production
2. Duration of animal welfare impact
3. Proportion of animals affected and suffering pain/injury/distress as a result of the disease
Impact on public health – human health 0 1 2 3 4 4.16 /100
1. Impact of occurrence on human health
2. Likelihood of occurrence
3. Impact of occurrence on food safety
4. Transmissibility (spread from animals to humans)
5. Spread in humans
6. Bioterrorism potential
Impact on wider society 0 1 2 3 4 8.33 /100
1. Economic direct impact (including cumulative cost, e.g. enzootic vs. epizootic)
2. Economic indirect impact (social, market)
3. Agriterrorism potential
Impact on trade 0 1 2 3 4 6.25 /100
1. Impact on international trade due to existing regulations
2. Impact on EC trade due to existing regulations
3. Potential for regionalisation
4. Impact on security of food supply
Control tools +2 +1 0 −1 −2 16.66 /100
1. Appropriate diagnostics
2. Appropriate vaccines
3. Appropriate pharmaceuticals
Total Score
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(1)disease knowledge
(2)impact on animal health and welfare
(3)impact on public health
(4)impact on wider society
(5)impact on trade
(6)control tools
An interpretation guide (http://www.discontools.eu/upl/
1/default/doc/1233_PrioInterV3-1-20110303.pdf) was de-
veloped to help the expert groups decide on the appropri-
ate scores to apply to each criterion. The expert groups
were asked to reach a consensus for the scoring of each
criterion. A 5 – tiered scoring system was chosen as this
appeared to offer a greater flexibility across the various cri-
teria. The scoring scale applied to the 5-tiered system is as
follows: for the first five sections 0, +1; +2; +3; +4 are used;
for the sixth section dealing with control tool scores of +2;
+1; 0; −1; −2 are used. This scoring scale was selected to
highlight the differences in control tools for each disease
in the sense that if for a particular disease a vaccine exists
that has a high level of efficacy, quality, safety and avail-
ability, then a negative score will be attributed to the final
total score of the concerned disease to diminish its priority
as an effective tool is available. On the contrary, if control
tools are missing, then a positive score will be added to
the total score meaning that the disease will be higher in
the prioritised list of diseases.
The weighting coefficient for each level of a criterion
was computed as follows:
W ¼ 100
X  I
where W = the weighting coefficient, X is the maximum
score of a level within a criterion and I is the number of
levels within a criterion. This ensured that the maximum
score of each criterion was 100 and that the different
criteria were attributed the same weight in the overall
score.
As there are 6 criteria for each disease, the scores
could be grouped, listed, ranked or presented in a wide
range of ways using either the overall score or the indi-
vidual scores for each criteria.
Gap analysis model of control tools
The criteria, levels within each of the criteria, scores and
weighting coefficients that were used in the gap analysis
model can be viewed in Table 3. Gap analysis considered
3 areas: diagnostic, vaccine and pharmaceutical gaps.
The scoring system goes from +2 (important gap) to −2
(current tools are appropriate and no need to focus re-
search in this area). As with the prioritisation model, an
interpretation guide was developed to facilitate consistency
in scoring (http://www.discontools.eu/upl/1/default/doc/
1235_GapAna-Inter-V3-1.pdf).
Table 3 The gap analysis model: criteria considered, levels within
the criteria, scores and applied weighting coefficients (Coef)
Criteria Scores Coef Total
(score*coef)
Diagnostic tools 2 1 0 −1 −2 4.17 /100
1. Availabilitya
2. Prevention and control -
Differentiation of infected from
vaccinated (DIVA)
3. Strategic reserve
4. Capacity of production
5. Market potential
6. Affordable
7. Quality/stability durability
8. Sensitivity
9. Specificity
10. Reproducibility
11. Simplicity/ease of use
12. Speed
Vaccination tools 2 1 0 −1 −2 4.55 /100
1. Commercial availabilitya
2. Monitoring for infection in a
vaccinated population
3. Strategic reserve
4. Capacity of production
5. Market potential
6. Affordable
7. Quality/stability
8. Safety of vaccines
9. Efficacy
10. Immunity
11. Convenience of use
Pharmaceutical tools 2 1 0 −1 −2 4.55 /100
1. Availabilitya
2. Prevention and control
3. Strategic reserve
4. Capacity of production
5. Market potential
6. Cost
7. Quality
8. Safety animal
9. Safety consumer/user
concerns
10. Safety environment
11. Resistance
Total Score:
aA maximum score of 20 was given to the whole criterion when there isn’t any
product available (not even under development)
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Expert opinion elicitation
An expert group leader was appointed for each disease
and was asked to engage other experts. Where possible
each group was asked to include experts with laboratory
and diagnostic expertise, an epidemiologist, an industry
representative and an individual with economic/trade
expertise. The leader was expected to organise a physical
or e-meeting in order to provide the information as de-
scribed below. The names of the experts are published
on the DISCONTOOLS website.
The average number of experts per group was 7. For
43 of the 52 included diseases (83%) the expert groups
involved at least 4 members considered to cover the re-
quested expertise (diagnostic, epidemiology, industry,
economics). However for 9 diseases (17%), ≤3 experts
were included (i.e. contagious bovine pleuropneumonia,
swine influenza virus, peste des petits ruminants, rift valley
fever, liver fluke, bovine herpes virus type 1, leptospirosis,
salmonella, Crimean congo haemorrhagic fever).
Utility
DISCONTOOLS website
The DISCONTOOLS website contains two main sections:
(i) work group pages and (ii) the disease database. The
work group pages contain relevant minutes, documents
and presentations related to meetings of the project man-
agement board.
The disease database contains the full D&P, along with
a 2-page summary to make it easy to interpret the out-
come. All the available information can be filtered for
specific diseases or specific sections of the analysis and
the customized reports can be downloaded in.pdf or.xls
format. There is also a tool to enable web site users to
provide comments on the D&P to the DISCONTOOLS
secretariat. The prioritisation model and gap analysis
model can be consulted for one or more diseases simul-
taneously and the specific scores for individual levels of
criteria can be consulted or downloaded through custom
reports.
Ranking of diseases by prioritisation model, disease
category and gap analysis model
In Table 4, diseases are ranked based on the total score
of the prioritisation model. The Table is very useful in
terms of providing a ‘Big Picture’ view and shows that
the top ranked diseases comprise mostly zoonotic dis-
eases and epizootic (often exotic) diseases. This, in turn,
helps to guide funders who are working in an inter-
national environment and with a broad remit in terms of
priorities. In Table 5, the diseases were ranked within
disease category. This provides an opportunity to iden-
tify priorities within different research domains. As such,
funders with an interest in public health will look to
the zoonoses ranking. In contrast, funders focusing on
international trade will have a great interest in the epi-
zootic diseases ranking and funders who are focusing
on the efficiency of production, especially within indi-
vidual countries, will have a great interest in the rank-
ing of food producing animal complexes. The results of
the gap analysis model can be used to obtain more details
of the gaps in control tools. As an example, in Table 6 we
provide the scores of the gap analysis model for diagnos-
tics, vaccines and pharmaceuticals for the top 10 ranked
diseases within each disease category. In general, this table
highlights the major gap in pharmaceuticals for the epizo-
otic diseases which is not surprising as the availability of
antivirals for the majority of diseases is very limited or
non-existent at present. In contrast, for the food produ-
cing animal complexes, the picture is more diverse with,
dependent on the disease, remaining gaps in diagnostics
and vaccines and less so in pharmaceutical development.
For the zoonotic diseases, good diagnostics are generally
available and the analysis highlights the need for research
into vaccine development. It should be noted that, whilst
the gap is identified, in many cases, it is unlikely that a
pharmaceutical solution would be pursued, for example
Bluetongue.
Discussion
The aim of the DISCONTOOLS project was to build a
prioritisation model and gap analysis on control tools as
a means of prioritising research on infectious animal
diseases with the support of stakeholders via a very
open consultation process in the animal health research
community.
The major achievement of this project consists of the
wide and standardized consultation of the animal health
research community, involving a total of 342 animal
health scientists from all over the world. The establish-
ment of expert groups was an important step in itself
because it brought together scientists from different
backgrounds and expertise often leading to lively debate,
the challenge of assumptions and the identification of
research gaps within their field. Where expert groups
could not reach consensus, this was recorded in the
D&P under the “Gap” section because it represents a
gap in knowledge that needs to be filled by research.
An example is the benefit of bees to pollination. At
the outset of the discussion, it was suggested by some of
the participants that crop yields could decline by 65%
without bees. However, when it was pointed out that
wild insects have a more important role in pollination
than honey bees, major crop species such as cereals are
self-pollinating and many others are wind pollinated
[27], it was agreed that the impact would be consider-
ably less and it was noted that work needs to be done in
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this area to determine the real impact. Having had this
discussion, it was recognised that efforts should be made
to control Varroa mite as the bee sector – with its vari-
ous products – is valuable (roughly estimated in the
consortium at €640 million per annum) and needs to be
protected.
As was done in Table 3, it is possible to rank diseases
by total scores of the prioritisation model. The total
score is valuable in highlighting the overall importance
of some diseases. Nipah virus obtained the highest score.
This was an interesting outcome and its high ranking is
confirmed in other recent studies to prioritize diseases
of food-producing animals and zoonoses [25, 28]. In the
case of FMD, it scores highly due to knowledge gaps
along with its impact on animal health and welfare, soci-
ety and trade even though we have good diagnostics and
vaccines. Given the impact of the disease, we need heat
stable multi-valent vaccines and need to focus research
in this area.
It might be surprising that the overall total for FMD
(310) in the prioritisation model is lower than that for
ASF (373) but an examination of the score in each of
the six separate categories (Table 2) which make up the
prioritisation model it is apparent where the variation
exists. In the case of ASF the score is higher for the
impact on international trade, animal health and wel-
fare and significantly higher for control tools where
there is no vaccine and diagnostic tests need to be
improved.
Despite the maximally standardized consultation rounds
and the use of a validation system in the form of Work
Packages 2 and 3 and the PMB, the final ranking of dis-
eases should be interpreted with caution. The total scores
also hide specific research needs within a disease. In the
case of nematodes for example, the total score hides the
pressing need to assign resources to the development of
vaccines in this area [29]. To avoid the user missing key
data, the “Interpretation of the Scores Guide” was devel-
oped as well as the two page summary for each disease.
Table 4 Ranking of 52 infectious diseases of animals by the
overall score of the prioritisation model
Disease Overall score
Nipah virus 464
Peste des petits ruminants 385
African swine fever 373
Rift valley fever 365
Bovine tuberculosis 359
Foot and mouth disease 310
Non tse-tse transmitted animal trypanosomiasis 296
African horse sickness 294
Cryptosporidiosis 291
Salmonellosis 282
Contagious bovine pleuropneumonia 269
Leishmaniosis 262
Brucellosis 254
Leptospirosis 250
Classical swine fever 247
Lumpy skin disease 244
Bluetongue 241
Orthopox 237
Hepatitis E virus 237
Poultry coccidiosis 226
Paratuberculosis 223
Anthrax 220
Campylobacter 219
Sheep and goat pox virus 218
Q-fever 214
Rabies 212
Avian Influenza 209
Verocytotoxigenic Escherichia coli 209
Liver fluke 202
Chlamydophila abortus 197
Nematodes 193
Porcine circo virus type 2 183
Bovine viral diarrhoea virus 183
Bovine spongiform encephalopathy 180
Small ruminant mastitis 179
Varroa mite 177
Staphylococcus aureus mastitis 175
Theileria 174
Mycoplasma bovis 173
Echinococcosis 167
Swine influenza virus 162
Congo crimean haemorrhagic fever 162
Swine Actinobacillus pleuropneumonia 159
Table 4 Ranking of 52 infectious diseases of animals by the
overall score of the prioritisation model (Continued)
Bovine respiratory syncytial virus 153
Parapox 152
Swine mycoplasma 143
Cysticercosis 130
Swine vesicular disease 118
West Nile Virus 118
Bovine herpes virus type 1 107
Porcine reproductive and respiratory syndrome virus 107
Environmental/Streptococcal mastitis 83
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The latter is of particular assistance to the non-specialist
user who wants an overview of the critical research needs.
Depending on the aim of the research, it may be more
informative to compare specific criteria only between
diseases (e.g. disease knowledge, impact on wider soci-
ety, etc.). Two critical factors that can affect the results
are: (i) the choice of the weighting coefficients and (ii)
the different composition of each expert group. The
different criteria of the prioritisation model such as dis-
ease knowledge, impact on animal health and welfare,
etc. received an equal weight. However, depending on
the user, different weight attributions may be desirable.
Recently, novel methods have been developed to iden-
tify criteria important to different stakeholders by using
the nominal group technique and attribute relative
weights to the criteria using a wide consultation of dif-
ferent stakeholders and conjoint analysis [26]. This can
result in different rankings according to the criteria and
weights defined by different stakeholders (e.g. the public
vs. health professionals) and provide additional insights to
the decision maker on the spending of research funds
[19]. In contrast to other prioritisation studies where all
diseases were scored by the same expert panel, e.g.
[13, 28], in the DISCONTOOLS project, each disease
was scored by a different expert panel. This may have
introduced bias due to inter-personal differences in scor-
ing, but was considered necessary in order to adequately
capture the current status of knowledge and gaps for con-
trol tools for each disease.
The epidemiological situation of infectious animal
diseases can change rapidly (e.g. the current epidemic of
the new porcine epidemic diarrhoea virus [30]), and bio-
technological developments constantly change the land-
scape of diagnostics, vaccines and pharmaceuticals. As a
consequence, the prioritisation exercise should be re-
peated regularly [28]. To this end, the database has been
placed on a public website with the possibility that the
public and research community can provide comments.
This was deliberately done to provide an environment
where the information in the D&P and the scores could be
challenged. The idea is to gather comments over time and
then ask the expert group to consider comments made
and adjust the information and scoring on the site as
appropriate. It is foreseen that the diseases will be sys-
tematically reviewed by the expert groups over a 5-year
cycle, taking on board the latest technical advances. In
fact, this process has already commenced and updated
information on the site is available for African swine
fever, Foot and mouth disease, Nematodes and Verocy-
totoxigenic E. coli.
Conclusion
A database was established with the intention of identifying
and prioritising research needs in the control of infectious
Table 5 Ranking of 52 infectious diseases of animals by disease category based on the prioritisation model
1. Epizootic diseases Score 2. Food producing animal complexes Score 3. Zoonoses Score
Peste des petits ruminants 385 Poultry coccidiosis 226 Nipah virus 464
African swine fever 373 Paratuberculosis 223 Bovine tuberculosis 359
Rift valley fever 365 Liver fluke 202 Non tse-tse transmitted animal
trypanosomiasis
296
Foot and mouth disease 310 Nematodes 193 Cryptosporidiosis 291
African horse sickness 294 Porcine circo virus type 2 183 Salmonellosis 282
Contagious bovine pleuropneumonia 269 Bovine viral diarrhoea virus 183 Leishmaniosis 262
Classical swine fever 247 Small ruminant mastitis 179 Brucellosis 254
Lumpy skin disease 244 Varroa mite 177 Leptospirosis 250
Bluetongue 241 Staphylococcus aureus mastitis 175 Hepatitis E virus 237
Orthopox 237 Theileria 174 Anthrax 220
Sheep and goat pox virus 218 Mycoplasma bovis 173 Campylobacter 219
Avian Influenza 209 Swine influenza virus 162 Q-fever 214
Parapox 152 Swine Actinobacillus pleuropneumonia 159 Rabies 212
Swine vesicular disease 118 Bovine respiratory syncytial virus 153 Verocytotoxigenic Escherichia coli 209
West Nile Virus 118 Swine mycoplasma 143 Chlamydophila abortus 197
Bovine herpes virus type 1 107 Bovine spongiform encephalopathy 180
Porcine reproductive and respiratory
syndrome virus
107 Echinococcosis 167
Environmental/Streptococcal mastitis 83 Congo crimean haemorrhagic fever 162
Cysticercosis 130
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animal diseases in the EU. If the focus of research is now
placed on the priorities identified, it will hasten the devel-
opment of diagnostics, vaccines and pharmaceuticals and
reduce the 20% loss in production potential, valued at €28
billion per year in the EU. Funders of research including
the European Commission, member states, foundations,
trusts along with private industry should use the database
to prioritise and focus future research. This will deliver
benefits in terms of animal health and welfare but also
public health, societal benefits and a safe and secure
food supply. The employed method and results should
not be considered fixed, but by refining the scoring
methodology, challenging and updating the available
information on a regular basis and incorporating new
diseases, the DISCONTOOLS database has the poten-
tial to become a reference point used by stakeholders
when prioritising research.
Endnotes
1www.etpgah.eu
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Table 6 Scores from the gap analysis model for the top-10
ranked diseases within each disease categorya
Disease Diagnostics Vaccines Pharmaceuticals
1. Epizootic diseases
Peste des petits ruminants −5 −10 20
African swine fever −50 40 40
Rift valley fever 29 18 40
Foot and mouth disease −32 −20 40
African horse sickness −18 20 10
Contagious bovine pleuro
pneumonia
9 30 25
Classical swine fever −23 −50 40
Lumpy skin disease 27 −5 40
Bluetongue −27 −15 40
Orthopox 18 40 15
2. Food producing animal complexes
Coccidiosis 9 5 −35
Paratuberculosis 0 0 40
Liver fluke −9 40 −25
Nematodes −5 40 −65
Bovine viral diarrhoea virus −27 −10 40
Porcine circo virus type 2 20 −40 40
Small ruminant mastitis −23 −5 −50
Varroa mite 40 40 −10
Staphylococcus aureus
mastitis
14 0 −30
Theileria 27 40 −30
3. Zoonotic diseases
Nipah virus 0 0 0
Bovine tuberculosis −18 10 40
Non tse-tse transmitted
trypanosomiasis
32 40 15
Cryptosporidiosis 0 40 −45
Salmonellosis −23 −30 −35
Leishmaniosis −14 35 −20
Brucellosis −5 20 40
Leptospirosis −5 5 −60
Hepatitis E virus −32 40 40
Anthrax 36 5 −45
Positive scores (indicating a gap) were highlighted in bold
aDecimals were rounded to the first integer. This may cause apparent
deviations between the sum of the individual and the total score
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